Abstract

Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) therapy is a rescue strategy for severe cardiopulmonary failure. The estimation of cardiac output during VA-ECMO is challenging. A lung circuit ({dot{text{Q}}}Lung) and an ECMO circuit ({dot{text{Q}}}ECMO) with oxygenators for CO2 removal (mathop {text{V}}limits^{.}CO2) and O2 uptake (mathop {text{V}}limits^{.}O2) simulated the setting of VA-ECMO with varying ventilation/perfusion (mathop {text{V}}limits^{.}/{dot{text{Q}}}) ratios and shunt. A metabolic chamber with a CO2/N2 blend simulated mathop {text{V}}limits^{.}CO2 and mathop {text{V}}limits^{.}O2. {dot{text{Q}}}Lung was estimated with a modified Fick principle: {dot{text{Q}}}Lung = {dot{text{Q}}}ECMO × (mathop {text{V}}limits^{.} CO2 or mathop {text{V}}limits^{.}O2Lung)/(mathop {text{V}}limits^{.}CO2 or mathop {text{V}}limits^{.}O2ECMO). A normalization procedure corrected mathop {text{V}}limits^{.}CO2 values for a mathop {text{V}}limits^{.}/{dot{text{Q}}} of 1. Method agreement was evaluated by Bland–Altman analysis. Calculated {dot{text{Q}}}Lung using gaseous mathop {text{V}}limits^{.}CO2 and mathop {text{V}}limits^{.}O2 correlated well with measured {dot{text{Q}}}Lung with a bias of 103 ml/min [− 268 to 185] ml/min; Limits of Agreement: − 306 ml/min [− 241 to − 877 ml/min] to 512 ml/min [447 to 610 ml/min], r2 0.85 [0.79–0.88]). Blood measurements of mathop {text{V}}limits^{.}CO2 showed an increased bias (− 260 ml/min [− 1503 to 982] ml/min), clinically not applicable. Shunt and mathop {text{V}}limits^{.}/{dot{text{Q}}} mismatch decreased the agreement of methods significantly. This in-vitro simulation shows that mathop {text{V}}limits^{.}CO2 and mathop {text{V}}limits^{.}O2 in steady-state conditions allow for clinically applicable calculations of {dot{text{Q}}}Lung during VA-ECMO therapy.

Highlights

  • Veno-arterial extracorporeal membrane oxygenation (VA-Extracorporeal membrane oxygenation (ECMO)) therapy is a rescue strategy for severe cardiopulmonary failure

  • This in-vitro simulation shows that VCO2 and VO2 in steady-state conditions allow for clinically applicable calculations of Q Lung during Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) therapy

  • The simulation consisted of two parallel circuits—one representing the ECMO blood flow with extracorporeal gas exchange, the other lung and heart—merged into the systemic circulation (Fig. 1)

Read more

Summary

Introduction

Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) therapy is a rescue strategy for severe cardiopulmonary failure. This in-vitro simulation shows that VCO2 and VO2 in steady-state conditions allow for clinically applicable calculations of Q Lung during VA-ECMO therapy. Extracorporeal membrane oxygenation (ECMO) has gained widespread interest as a rescue therapy for severe pulmonary or circulatory failure and its use grows e­ xponentially[1]. In a parallel connection to the patient’s own circulation, veno-arterial ECMO drains venous blood from the patient into an extracorporeal membrane lung, where carbon dioxide is removed and hemoglobin in the red blood cells is oxygenated. The physiology of gas exchange and blood flow with two competing systems, the ECMO and the patient’s own heart and lung in parallel connection, is incompletely ­understood[4]. The goal of the treatment is to maintain tissue perfusion and gas exchange in order

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.